Small Biotech Firms That Can Become Top-Tier Biotech Giants
We Start With...
Abeona Therapeutics
Abeona Therapeutics (ABEO) is a clinical-stage biopharmaceutical gene and cell therapy company. In September 2016 Abeona acquired an exclusive worldwide license of a next-generation gene therapy AAV capsid portfolio from University of North Carolina at Chapel Hill. The AIM™ vector system . . .
This content is for paid subscribers.
Today’s Highlights
July 2, 2019
